Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Acta Pharmaceutica
Volume 72 (2022): Issue 3 (September 2022)
Open Access
Design and development of novel 1,2,3-triazole chalcone derivatives as potential anti-osteosarcoma agents
via
inhibition of PI3K/Akt/mTOR signalling pathway
Qing Su
Qing Su
,
Baolin Xu
Baolin Xu
,
Zhoubin Tian
Zhoubin Tian
and
Ziling Gong
Ziling Gong
| Apr 13, 2022
Acta Pharmaceutica
Volume 72 (2022): Issue 3 (September 2022)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Apr 13, 2022
Page range:
389 - 402
Accepted:
Dec 14, 2021
DOI:
https://doi.org/10.2478/acph-2022-0026
Keywords
1,2,3-triazole-chalcone hybrids
,
osteosarcoma
,
kinase inhibition
© 2022 Qing Su et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Qing Su
Department of Orthopedic Oncology, Yantai Shan Hospital
Yantai, China
Baolin Xu
Department of Orthopedics, The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, China
Zhoubin Tian
Department of Joint Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University
Jinan, China
Ziling Gong
Department of Orthopaedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital
Shanghai, China